Omecamtiv Mecarbil Modulates the Kinetic and Motile Properties of Porcine β-Cardiac Myosin-Reference-Cited by-同舟云学术

Omecamtiv Mecarbil Modulates the Kinetic and Motile Properties of Porcine β-Cardiac Myosin

Published:2015-03-04 Issue:10 Volume:54 Page:1963-1975
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Liu Yingying¹,White Howard D.¹,Belknap Betty¹,Winkelmann Donald A.²,Forgacs Eva¹

Affiliation:

1. Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23507, United States

2. Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey 08854, United States

Funder

National Heart, Lung, and Blood Institute

American Heart Association

Thomas F. and Kate Miller Jeffress Memorial Trust

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi5015166

Reference42 articles.

1. Epidemiology of Heart Failure and Scope of the Problem

2. The Year in Heart Failure

3. Heart Failure: Pathophysiology and Clinical Picture

4. Inotropes in the management of acute heart failure

5. Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myosin Isoform-Dependent Effect of Omecamtiv Mecarbil on the Regulation of Force Generation in Human Cardiac Muscle;International Journal of Molecular Sciences;2024-09-10

2. Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release;PNAS Nexus;2024-07-16

3. Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction;Nature Communications;2024-06-07

4. Myosin-Catalyzed ATP Hydrolysis in the Presence of Disease-Causing Mutations: Mavacamten as a Way to Repair Mechanism;The Journal of Physical Chemistry B;2024-05-06

5. Harnessing molecular mechanism for precision medicine in dilated cardiomyopathy caused by a mutation in troponin T;2024-04-09